Altered urinary profiles of polyamines and endogenous steroids in patients with benign cervical disease and cervical cancer

Cancer Letters

Volumn 201, Issue 2, 2003, Pages 121-131

  Lee, Seon Hwa ^a   Yang, Yoon Jung ^a   Kim, Kyung Mee ^a   Chung, Bong Chul ^a  

^a Korea Institute of Science and Technology   (South Korea)

Author keywords

Androgens; Cervical cancer; Corticoids; Estrogens; Gas chromatography mass spectrometry; Gas chromatography nitrogen phosphorus detection; Polyamines

Indexed keywords

1,3 DIACETYLPROPANE; 16ALPHA HYDROXYESTRONE; 17ALPHA ESTRADIOL; 2 HYDROXYESTRONE; 2 METHOXYESTRONE; 5ALPHA TETRAHYDROCORTISONE; 5BETA TETRAHYDROCORTISONE; ANDROGEN; ANDROSTERONE; CADAVERINE; ESTRADIOL; ESTRIOL; ESTROGEN; ESTRONE; ETIOCHOLANOLONE; HYDROCORTISONE DERIVATIVE; N ACETYLCADAVERINE; N ACETYLPUTRESCINE; N1 ACETYLSPERMIDINE; N1 ACETYLSPERMINE; N1,N12 DIACETYLSPERMINE; N8 ACETYLSPERMIDINE; POLYAMINE; PUTREACINE; PUTRESCINE; SPERMIDINE; SPERMINE; STEROID; TESTOSTERONE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ADULT; ANALYTICAL EQUIPMENT; ANDROGEN METABOLISM; ARTICLE; CARCINOGENESIS; CHEMICAL PARAMETERS; CLINICAL ARTICLE; CONTROLLED STUDY; ESTROGEN METABOLISM; ESTROGEN URINE LEVEL; FEMALE; GAS CHROMATOGRAPHY; HUMAN; ION MONITORING; MASS SPECTROMETRY; NITROGEN DETECTOR; POLYAMINE METABOLISM; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; STEROID HYDROXYLATION; STEROID URINE LEVEL; URINALYSIS; UTERINE CERVIX CANCER; UTERINE CERVIX DISEASE;

PAPILLOMAVIRUS;

EID: 0242384110     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(03)00014-4     Document Type: Article

References (27)

1. Mitchell M.F., Luna G.T., Lee J.J., Hittelman W.K., Lotan R., Wharton J.T., Hong W.K., Nishioka K. Polyamine measurements in the uterine cervix. J. Cell. Biochem. Suppl. 28/29:1997;125-132.
2. de villiers E.M., Schneider A., Mikilaw H., Papendick U., Wagner D., Wesh H., Wahrendorf J., Hausen H. Human papillomavirus infection in women with and without abnormal cervical cytology. Lancet. 2:1982;703-706.
3. Mitchell H., Drake M., Medley G. Prospective evaluation of risk of cervical cancer after cytological evidence on human papillomavirus infection. Lancet. 1:1986;573-575.
4. Gram I.T., Macaluso M., Stalsberg H. Oral contraceptive use and the incidence of cervical intraepithelial neoplasia. Am. J. Obstet. Gynecol. 167:1992;40-44.
5. Mori M., Sagae S. Recent progress in epidemiological research of uterine cancer. Gan. To. Kagaku. Ryoho. 28:2001;174-178.
6. Fernandez C., Sharrard R.M., Talbot M., Reed B.D., Monks N. Evaluation of the significance of polyamines and their oxidases in the aetiology of human cervical carcinoma. Br. J. Cancer. 72:1995;1194-1199.
7. Nishioka K., Melgarejo A.B., Lyon R.R., Mitchell M.F. Polyamines as biomarkers of cervical intraepithelial neoplasia. J. Cell. Biochem. Suppl. 23:1995;87-95.
8. Suh J.W., Lee S.H., Chung B.C., Park J. Urinary polyamine evaluation for effective diagnosis of various cancers. J. Chromatogr. 688:1997;179-186.
9. Lee S.H., Kim S.O., Lee H.D., Chung B.C. Estrogens and polyamines in breast cancer: their profiles and values in disease staging. Cancer Lett. 133:1998;47-56.
10. Auborn K.J., Woodworth C., Dipaolo J.A., Bradlow H.L. The interaction between HPV infection and estrogen metabolism in cervical carcinogenesis. Int. J. Cancer. 49:1991;867-869.
11. Sepkovic D.W., Bradlow H.L., Ho G., Hankinson S.E., Gong L., Osborne M.P., Fishman J. Estrogen metabolite ratios and risk assessment of hormone-related cancers; assay validation and prediction of cervical cancer risk. Ann. N.Y. Academy Sci. 30:1995;312-315.
12. Schneider A., Holz M., Gissmann L. Increased prevalence of human papillomaviruses in the lower genital tract of pregnant women. Int. J. Cancer. 40:1987;198-203.
13. Schiffman M.H. Recent progress in defining the epidemiology of human papillomavirus infection and cervical neoplasia. J. Natl. Cancer Inst. 84:1992;394-398.
14. Lee S.H., Kim S.O., Kwon S.W., Chung B.C. Androgen imbalance in premenopausal women with benign breast disease and breast cancer. Clin. Biochem. 32:1999;375-380.
15. Doeberitz M.V.K., Spitkovsky D., Ridder R. interactions between steroid hormones and viral oncogenes in the pathogenesis of cervical cancer. Verh. Dtsch. Ges. Path. 81:1997;233-239.
16. Doeberitz M.K., Oltersdorf T., Schwarz E., Gissmann L. Correlation of modified human papillomavirus early gene expression with altered cell growth in C4-1 cervical carcinoma cells. Cancer Res. 48:1988;3780-3786.
17. Vesanen M., Isomaa V., Alanko M., Vihko R. Bovine uterine, cervical and ovarian androgen receptor concentrations, Acta. Vet. Scand. 33:1992;379-386.
18. van den Berg G.A., Muskiet F.A.J., Kingma A.W., van der Silk W., Halle M.R. Simultaneous gas-chromatographic determination of free and acetyl conjugated polyamines in urine. Clin. Chem. 32:1986;1930-1937.
19. Schänzer W. and M. Donike, Metabolism of anabolic steroids in man: synthesis and use of reference substances for identification of anabolic steroid metabolites, Anal. Chim. Acta. 275:1993;23-48.
20. Lee S.H., Yang Y.J., Kim T.W., Paeng K.J., Chung B.C. Urinary profiling of endogeneous estrogens using GC/MS. J. Korea Chem. Soc. 41:1997;186-197.
21. Lee S.H., Choi M.H., Kim T.W., Chung B.C. Evaluation of endogeneous steroids profile after administration of anabolic steroids. J. Korea Chem. Soc. 41:1997;406-413.
22. Russell D.H., Giles H.R., Christian C.D., Campbell J.L. polyamines in amniotic fluid, plasma, and urine during normal pregnancy, Am. J. Obstet. Gynecol. 132:1978;646-652.
23. Becciolini A., Porciani S., Lanini A., Santoni R., Cionini L. Urinary polyamines in patients with advanced cervical cancer or pelvic cancer recurrence during and after radiotherapy. Acta. Oncologica. 31:1992;327-331.
24. Potish R.A., Twiggs L.B., Adcock L.L., Prem K.A., Savage J.E., leung B.S. Prognostic importance of progesterone and estrogen receptor in cancer of uterine cervix. Cancer. 58:1986;1709-1713.
25. Dimitrov O., Pavlov V., Jotova I. Effects of female sex hormones on polyamine-oxidizing enzyme activities and polyamine concentrations in immature rat uterus and liver. Experientia. 52:1996;795-798.
26. Swain M.C., Hayward J.L., Bulbrook R.D. Plasma oestradiol and progesterone in benign breast disease. Eur. J. Cancer. 9:1973;553-556.
27. Lee S.H., Nam S.Y., Chung B.C. Altered profile of endogeneous steroids in the urine of patients with prolactinoma. Clin. Biochem. 31:1998;529-535.